IL6 and Parkinson disease: In contrast to oxidative stress markers, TEMPOL did not exhibit anti-inflammatory effects in this cell model, as judged by an inability to affect 6-OHDA-mediated changes in IFNγ and IL-6, cytokines that are implicated in the pathogenesis of PD [48].